Myelofibrosis Post-polycythemia Vera
📧 Sign up to get email alerts when something new happens for Myelofibrosis Post-polycythemia Vera.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-05-12FDA Approved: INREBIC — Supplemental Application (Celgene Corporation)
The FDA approved a supplemental application for INREBIC (fedratinib hydrochloride) submitted by Celgene Corporation.